INVERSAGO-PHARMA
Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced that François Ravenelle, Ph.D., Chief Executive Officer, and Glenn Vraniak, MBA, Chief Financial Officer, will host investor meetings during the Private Company Exhibition at the 2023 SVB Securities Global Biopharma Conference being held January 31 through February 2, 2023.
For additional information or to request a meeting with management, please contact conference representatives.
About Inversago Pharma
Inversago Pharma is a privately owned, clinical stage, Canadian biotech company, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting CB1 inverse agonists. Inversago aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as diabetic kidney disease (DKD), including diabetic nephropathy (DN), type 1 and type 2 diabetes (T1D / T2D), non-alcoholic steatohepatitis (NASH), complications of obesity and hypertriglyceridemia (HTG), as well as fibrotic indications like progressive fibrosis-interstitial lung disease (PF-ILD), including idiopathic pulmonary fibrosis (IPF) and other conditions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005328/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vantage Data Centers Expands European Footprint with Second Italian Campus15.10.2025 14:00:00 CEST | Press release
State-of-the-art, sustainable Milan campus to deliver 32MW of IT capacity for digital transformation; company’s developments recognized by the Italian government as national strategic investments Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the expansion of its Italian footprint to include a second campus in Milan. With an investment of more than €350 million (approximately $407 million USD), the MXP2 campus is designed to support the growing demand for high-performance, scalable digital infrastructure in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015151520/en/ Vantage Data Centers’ growing Italian footprint includes a second Milan campus with 32MW of IT capacity. Located in Castelletto just 15 kilometers (less than 10 miles) from central Milan, the campus will feature two modern data centers delivering a combined 32MW of critical IT capacity across a
NetApp and the 49ers Foundation Launch Data Science Education Partnership15.10.2025 14:00:00 CEST | Press release
Multi-year initiative aims to empower students with hands-on tech learning at Levi’s® Stadium NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, and the 49ers Foundation, the largest team foundation in the NFL, today announced a multi-year partnership to provide data science education to high school students in the San Francisco Bay Area. The 49ers EDU Data Analytics Lessons Series seeks to inspire and equip the next generation of tech leaders with essential skills in data science and introduce students to career opportunities in technology. The partnership will enable NetApp and the 49ers Foundation to utilize the unique setting of Levi’s® Stadium to provide immersive educational experiences. This collaboration is part of the 49ers EDU STEAM education program and builds upon its impactful history of educating over a half a million students in the Bay Area and beyond through digital and in-person programming. 49ers EDU educators will lead all lessons part of the Data
Merck to Acquire the Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio15.10.2025 14:00:00 CEST | Press release
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutionsJSR’s innovative Amsphere™ Protein A resin technology complements Merck’s existing biologics portfolioEnhances Merck’s capabilities to accelerate next-generation therapies by optimizing antibody purification Merck, a leading science and technology company, today announced the signing of a definitive agreement to acquire the chromatography business of JSR Life Sciences, a leader in contract development and manufacturing, preclinical and translational clinical research, and bioprocessing solutions. The acquisition will expand Merck’s downstream processing portfolio with advanced Protein A chromatography capabilities, supporting more efficient and scalable production of biopharmaceutical therapies, including monoclonal antibodies. The transaction is expected to close by the end of the second quarter of 2026. This press release features multimedia. View the full release her
‘Warmer Together’: Moncler Celebrates Warmth and Love, With Legendary Friends Al Pacino and Robert De Niro15.10.2025 14:00:00 CEST | Press release
Moncler’s new campaign reunites two lifelong friends and icons of Hollywood for a cinematic expression of friendship, connection, and human warmth. Over seven extraordinary decades of evolution and innovation, Moncler has become synonymous with warmth, embracing the elements, and year-round performance and style. It’s true the brand was born in the Alps in 1952 with a mission to protect climbers and mountain workers from the extreme cold, but for Moncler, warmth was never about the outside. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015925807/en/ Al Pacino and Robert De Niro star in Moncler’s Warmer Together campaign. Courtesy of Moncler To manifest that essence, Moncler today unveils the new global statement, Warmer Together, bringing Al Pacino and Robert De Niro together for their first-ever shared campaign. Warmer Together goes beyond words, it is the heartbeat of Moncler’s purpose. From the very beginning, the bra
Josh Krichefski Joins PMG as EMEA President15.10.2025 13:00:00 CEST | Press release
Former WPP executive to lead and accelerate growth across PMG’s EMEA operations. PMG, a global independent marketing services and technology company, today announced the appointment of Josh Krichefski to EMEA President, effective October 20th. In this new role, Krichefski will lead the strategy and expansion of PMG’s operations across the region, with a focus on scaling growth and driving excellence in customer delivery. He will oversee all aspects of the EMEA business, including commercial performance, talent development, and the introduction of new capabilities and partnerships aligned to PMG’s global vision. Krichefskiwill be based in PMG’s London office and will partner directly with George Popstefanov, Founder & CEO and Jon Dupuis, Global President. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015978859/en/ Josh Krichefski Dupuis commented: “Josh’s appointment marks an exciting next chapter in our EMEA growth. With
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom